89Zr-labeled antibodies (Astellas Pharma/Okayama University)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Name89Zr-labeled antibodies (Astellas Pharma/Okayama University)
Drug Alias Name89Zr-IgG89Zr-Fab
ClassificationRadiation-emitting productsBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragment
Mechanisms of ActionPositron-emission tomography enhancers
TargetsUpdating
Therapy Area/Indications +[1N/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAstellas Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive Indications +[1N/A

Other Information

ATC CodeN/A
Related LinksN/A